399 related articles for article (PubMed ID: 33104189)
21. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
22. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.
Woo CH; Rao VA; Sheridan W; Flint AC
Neurocrit Care; 2009; 11(2):228-34. PubMed ID: 19533046
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.
Dominguez M; Perez JA; Patel CB
Methodist Debakey Cardiovasc J; 2013; 9(1):49-53. PubMed ID: 23519387
[TBL] [Abstract][Full Text] [Related]
24. Overcorrection of hyponatremia: where do we go wrong?
Pham PC; Chen PV; Pham PT
Am J Kidney Dis; 2000 Aug; 36(2):E12. PubMed ID: 10922333
[TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction.
Soupart A; Penninckx R; Stenuit A; Perier O; Decaux G
Kidney Int; 1992 Jun; 41(6):1662-7. PubMed ID: 1501423
[TBL] [Abstract][Full Text] [Related]
26. Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.
Rondon-Berrios H; Sterns RH
Am J Kidney Dis; 2022 Jun; 79(6):890-896. PubMed ID: 34508830
[TBL] [Abstract][Full Text] [Related]
27. Comparison of isotonic and hypotonic intravenous maintenance fluids: a randomized clinical trial.
Friedman JN; Beck CE; DeGroot J; Geary DF; Sklansky DJ; Freedman SB
JAMA Pediatr; 2015 May; 169(5):445-51. PubMed ID: 25751673
[TBL] [Abstract][Full Text] [Related]
28. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
Ward FL; Tobe SW; Naimark DMJ
Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
[TBL] [Abstract][Full Text] [Related]
29. Hyponatremia: a problem-solving approach to clinical cases.
Assadi F
J Nephrol; 2012; 25(4):473-80. PubMed ID: 22307436
[TBL] [Abstract][Full Text] [Related]
30. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
31. Management of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?
Tzamaloukas AH; Shapiro JI; Raj DS; Murata GH; Glew RH; Malhotra D
Am J Med Sci; 2014 Nov; 348(5):432-9. PubMed ID: 25247759
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of oral versus intravenous hypertonic saline in runners with hyponatremia.
Owen BE; Rogers IR; Hoffman MD; Stuempfle KJ; Lewis D; Fogard K; Verbalis JG; Hew-Butler T
J Sci Med Sport; 2014 Sep; 17(5):457-62. PubMed ID: 24148616
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in the management of acute and chronic hyponatremia.
Hoorn EJ; Spasovski G
Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):424-432. PubMed ID: 31232710
[TBL] [Abstract][Full Text] [Related]
34. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
35. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
[TBL] [Abstract][Full Text] [Related]
36. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea.
Soupart A; Stenuit A; Perier O; Decaux G
Clin Sci (Lond); 1991 Jan; 80(1):77-84. PubMed ID: 1846795
[TBL] [Abstract][Full Text] [Related]
37. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage.
Suarez JI; Qureshi AI; Parekh PD; Razumovsky A; Tamargo RJ; Bhardwaj A; Ulatowski JA
J Neurosurg Anesthesiol; 1999 Jul; 11(3):178-84. PubMed ID: 10414672
[TBL] [Abstract][Full Text] [Related]
38. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
[TBL] [Abstract][Full Text] [Related]
39. Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double-blinded, randomised controlled trial.
Li Q; Chen H; Hao JJ; Yin NN; Xu M; Zhou JX
BMC Anesthesiol; 2015 Oct; 15():138. PubMed ID: 26445777
[TBL] [Abstract][Full Text] [Related]
40. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial.
Wu S; Baker C; Lang ME; Schrager SM; Liley FF; Papa C; Mira V; Balkian A; Mason WH
JAMA Pediatr; 2014 Jul; 168(7):657-63. PubMed ID: 24862623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
